Key result
Beta-blocker therapy in idiopathic dilated cardiomyopathy improved left ventricular ejection fraction in 26 of 32 patients, which was associated with favorable changes in myocardial gene expression.
Why the study?
Does beta-blocker therapy alter myocardial gene expression and improve left ventricular ejection fraction in patients with idiopathic dilated cardiomyopathy?
Population
53 patients with idiopathic dilated cardiomyopathy
Comparison
Beta-adrenergic-receptor blocking agent for 6… vs Placebo
Design
RCT, randomly assigned
Follow-up
6 months
Authors
Loading...
Supports beta-blocker use in idiopathic dilated cardiomyopathy; extends evidence by linking benefit to myocardial gene expression changes.
RCT (n=53)
Randomized
Does beta-blocker therapy alter myocardial gene expression and improve left ventricular ejection fraction in patients with idiopathic dilated cardiomyopathy?
Functional improvement from beta-blocker therapy in idiopathic dilated cardiomyopathy is associated with favorable alterations in myocardial gene expression regulating contractility and hypertrophy.
Lowes et al. (2002) conducted an RCT in Idiopathic dilated cardiomyopathy (n=53). Beta-adrenergic-receptor blocking agent (metoprolol or carvedilol) vs. Placebo was evaluated on Changes in gene expression compared with changes in left ventricular ejection fraction. Beta-blocker therapy in idiopathic dilated cardiomyopathy improved left ventricular ejection fraction in 26 of 32 patients, which was associated with favorable changes in myocardial gene expression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: